Cargando…
P008 Molecular mechanisms associated with fluconazole resistance and genetic diversity in clinical Candida krusei isolates from North India
POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Candida krusei accounts for 2.8% of invasive candidiasis worldwide. Fluconazole resistance and its underlying mechanism in clinical isolates of C. krusei (n = 137) collected from eight hospitals in India were investigated. Also,...
Autores principales: | Jain, Kusum, Shivarathri, Raju, Bashir, Gulnaz, Chauhan, Neeraj, Chowdhary, Anuradha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509707/ http://dx.doi.org/10.1093/mmy/myac072.P008 |
Ejemplares similares
-
P021 Comparative transcriptomic analysis of environmental Candida auris showing variable azole susceptibility
por: Jain, Kusum, et al.
Publicado: (2022) -
P357 Update on risk factors for Candida krusei-Fungemia
por: Jansen, Julia C., et al.
Publicado: (2022) -
Genetic Differentiation, Diversity, and Drug Susceptibility of Candida krusei
por: Gong, Jie, et al.
Publicado: (2018) -
Cardiac Candida krusei infection
por: Wiwanitkit, Viroj
Publicado: (2010) -
The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris
por: Shivarathri, Raju, et al.
Publicado: (2020)